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 xviii 
KAJIAN DOSIMETRI GELATIN GENIPIN: BAHAN KIMIA 
TAMBAHAN- GEL POLIMER MENGGUNAKAN KEMUDAHAN 
TERAPEUTIK 6MV DAN 10MV 
 
ABSTRAK 
Nanopartikel emas AuNPs dari bahan bernombor atom (Z) tinggi, garam 
bukan organik dan glukosa telah digunakan dalam kajian ini untuk meningkatkan 
sifat-sifat fizikal dan radiologi genipin dosimeter gel untuk aplikasi klinikal yang 
berbeza. Keberkesanan bahan tambah ini telah dikaji untuk  respon penyerapan dos 
yang optimum, ketelusan, takat lebur, ketumpatan, dan kesetaraan air terhadap 
pengukuran dos secara 3D. Formulasi gel boleh harap yang baharu (GP-Gl-AuNPs) 
telah diformulasi dan dinilai untuk dosimetri 3D menggunakan penilaian optik dan 
teknik pengimbasan CT untuk bacaan dos. Penambahan glukosa  dengan kepekatan 
optimum 10% (w/w) didapati telah meningkat kestabilan terma gel genipin dan 
meningkatkan takat lebur (Tm) sebanyak 6°C. Tambahan pula, glukosa membantu 
melaraskan ketumpatan jisim gel untuk memperoleh sifat-sifat kesetaraan yang 
dikehendaki. Setitik Tm dan kekuatan gel diperhatikan apabila garam digunakan 
sebagai bahan tambah. Dengan peningkatan kepekatan garam, kekuatan gel dan Tm 
menurun. Kesetaraan radiologi air bagi setiap genipin gel dosimeter ditentukan 
dengan menilai ketumpatan, nombor atom berkesan, dan pekali pengecilan linear. 
Kesemua nilai dibandingkan dengan nilai air dan otot, membuktikan bahawa sifat 
radiologi gel baharu adalah menghampiri nilai otot dan boleh dianggap sebagai gel 
setara air. 
  
 xix 
Tindak balas maksimum dos optik gel genipin pada foton 6 dan 10 MV 
adalah masing-masing -0.00526 dan -0.00522 (cm
-1
Gy
-1
). Penambahan AuNPs 
(kepekatan optimum, 200 ppm), menghasilkan sedikit peningkatan dos optik kurang 
daripada 10%. Mengikut lengkok kalibrasi ketumpatan yang diperolehi dari 
pengimbas CT, ketumpatan sampel gel telah diekstrak menggunakan CTNs yang 
sama. Hasil menunjukan peningkatan ketumpatan gel lebih kurang mengikut urutan 
0.5 mg cm
–3
Gy
-1
 disebabkan oleh penyinaran. Pengiraan resolusi dos juga 
menunjukkan bahawa gel GP-Gl-AuNPs meningkatkan resolusi dos (~0.05 Gy). 
Peratus kedalaman dos (PDDs) dan profil dos alur foton 6-MV menggunakan kebuk 
pengionan (IC), GP-Gl-AuNPs, dan filem EBT3 untuk  saiz bidang (100 × 100) 
mm
2
)  dikaji untuk perbandingan dan pengesahan. Berdasarkan keputusan, perbezaan 
peratusan maksimum mutlak antara ukuran PDD GP-Gl-AuNPs dengan IC dan 
EBT3 filem adalah 4% dan 6%. Kesamarataan IC, GP-Gl-AuNPs dan EBT3 filem 
masing-masing ialah 2.2%, 2.1% dan 1.8%, manakala simetri IC, genipin -Gl-AuNPs 
dan EBT3 filem masing-masing ialah 0.9% 1.0% dan 0.8%. Kajian ini memberi 
sumbangan yang besar ke arah pembangunan dan kejayaan pelaksanaan dosimetri 
gel terhadap radioterapi klinikal. 
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DOSIMETRIC STUDY OF GENIPIN GELATIN-CHEMICAL 
ADDITIVES POLYMER GEL USING 6 MV AND 10 MV 
THERAPEUTIC FACILITIES 
 
ABSTRACT 
Gold nanoparticles AuNPs of high-Z materials, inorganic salts and glucose 
have been used in this study to enhance physical and radiological properties of 
genipin gel dosimeter for different clinical applications. The effectiveness of these 
additives were investigated for optimum visible absorption dose response, 
transparency, melting points, density, and water equivalency for 3D dose 
measurements. A reliable new gel formulation (GP -Gl-AuNPs) was formulated and 
evaluated for 3D dosimetry using optical evaluation and CT scanning techniques for 
dose readout. The addition of glucose with optimum concentration of 10% (w/w) was 
found to improve the thermal stability of the genipin gel and increase its melting 
point (Tm) by 6°C. Furthermore, glucose helps to adjust the gel mass density to 
obtain the desired tissue-equivalent properties. A drop of Tm and the gel strength 
were observed when salt was used as additives. As the salt concentration increase, 
gel strength and Tm decreased. The radiological water equivalence of each genipin 
gel dosimeters was determined by evaluating the densities, effective atomic numbers, 
and the linear attenuation coefficients. All of these values were compared with water 
and muscle values, proving that the radiological properties of the new gel 
approximate muscle values and could be considered as a water equivalent gel. 
 
 xxi 
The maximum optical dose responses of genipin gel at 6 and 10 MV photon 
beams were –0.00526 and –0.00522 (cm–1Gy–1) respectively. The addition of AuNPs 
(optimum concentration, 200 ppm) has resulted in a slight increment of the optical 
dose response of less than 10%. According to the density calibration curve obtained 
from CT scan, the gel sample densities were extracted using the corresponding 
CTNs. The result displayed an increment of gel density approximately in the order of 
0.5 mg cm
–3
Gy
–1
 due to irradiation. The dose resolutions calculations were also 
indicated that GP–Gl–AuNPs gel enhanced dose resolution (~0.05 Gy).The percent 
depth doses (PDDs) and dose profiles of 6 MV photon beams using an ionization 
chamber (IC), GP–Gl–AuNPs, and EBT3 films of field sizes (100 × 100 mm2) were 
investigated for comparison and verification purpose. According to the results, the 
maximum absolute percentage difference between the PDD measurements of GP–
Gl–AuNPs with IC and EBT3 films were 4% and 6%. The ﬂatness of the IC, GP–Gl–
AuNPs and EBT3 films were 2.2%, 2.1% and 1.8%, respectively, while the 
symmetry of the IC, GP–Gl–AuNPs and EBT3 films were 0.9% 1.0% and 0.8% 
respectively. This study provides a significant contribution toward the development 
and successful implementation of gel dosimetry towards clinical radiotherapy. 
. 
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CHAPTER 1  
INTRODUCTION 
 
1.1 Background 
Since the discovery of ionizing radiation (IR), x-rays and radioactivity at the 
end of the 19th century, the biological effects of radiation have been recognized. Its 
ability to damage cells by producing free radicals and intermediate ions is utilized to 
induce cell inactivation and death. Subsequently, throughout the 20
th
 century, IR has 
been introduced as an essential therapeutic tool in clinical oncology. Over the years, 
several therapeutic techniques, such as intensity-modulated radiotherapy (IMRT), 
image-guided radiation therapy (IGRT) and intraoperative radiation therapy (IORT) 
have been proposed to improve the optimal delivery of IR to patients (Bruner et al., 
2001; Delaney et al., 2005; Radiation, 2009). At present, accurate dose delivery has 
significantly improved, allowing more precise deposition of dose in tumors while 
gradually reducing any unwanted dose to surrounding healthy tissues (Bhide & 
Nutting, 2010; Begg et al., 2011). 
Radiation therapy is the treatment of cancer and other diseases by damaging 
the genetic material within target cells with IR, in which radiation can be delivered 
via two modes, namely, externally and internally. In both cases, IR deposits energy 
as it traverses an absorbing medium can cause damage in target cells or prevent these 
cells from proliferating and dividing (Feinendegen et al., 2004; Wang et al., 2008). 
However, cell damage increases with the increase in amount of energy deposited in a 
mass of tissue, which is termed as absorbed dose (ICRU, 1998). Thus, absorbed dose 
(D) should be measured in numerous applications. Several effective dosimetry 
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systems have been developed in the past century. In radiotherapy, dose measurement 
is of major significance, especially in medical practice. The accurate measurement of 
the dose imparted to target cells is fundamental in studies of clinical radiotherapy 
practice, as well as in biological effects of irradiation. 
Radiation measurements and the study of radiation effects demand different 
specifications of the radiation field at the point of concern. Radiation dosimetry deals 
with methods of quantitatively determining the energy deposited in a given medium 
by direct or indirect IR (Podgorsak, 2005). Since the inception of IR over a century 
ago, radiotherapy has become one of the primary tools for treating cancerous cells, 
with an estimated 50% of all patients who developed cancer requiring radiotherapy at 
certain phases of their illness (NHMRC, 1996; Begg et al., 2011). Radiotherapy 
treatment is planned based on the dose required to achieve the clinical objective and 
the dose constraints of the organs at risk. To optimize the possibility of tumor 
control, a high dose of radiation to the tumor volume is required (Connell & 
Hellman, 2009). Major developments have been achieved to address the problem of 
limited effect on deep-seated tumors because of low penetration in addition to high 
x-ray dosage delivery. 
Besides widening the array of beam energies, technological growth in 
radiotherapy equipment has also improved tumor targeting while reducing the 
radiation dose to neighboring healthy tissues. In the past 20 years, numerous 
sophisticated techniques have been developed, such as the application of electron 
linear accelerator machines (LINACs) to produce higher-energy x-rays and electron 
beams in the megavoltage range of energy for radiotherapy (Lind & Brahme, 1995). 
Enhancement in dose distribution and skin sparing via high-energy x-rays has 
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improved and continues to increase the effectiveness of radiotherapy in treating 
cancer, given that tumor cells can be bombarded with a sufficient dose of radiation 
without causing severe reaction to the skin or adjacent healthy tissues (Bernier et al., 
2004).  
Dosimetry is a key component of radiotherapy that entails the measurement 
or calculation of a dose deposited in a given medium, in which dose is the 
differential energy imparted per unit mass. Dosimetry techniques are used to 
compare the planned (treatment planning system predicted) dose distribution to the 
measured dose distribution in a given volume (Schreiner, 2006). For a complex dose 
distribution, the measurement of the whole dose distribution would be preferential in 
evaluating whether the dose had been deposited accurately. A radiation dosimeter is 
a device, instrument, or system that measures or evaluates, either directly or 
indirectly, the quantity of exposure, absorbed dose or equivalent dose, their time 
derivatives (rates), or related quantities of IR (Attix, 2008). A dosimeter with its 
reader is called a dosimetry system. The operating parameters of a radiation 
dosimeter are dependent on at least one physical property upon which the dosimetric 
quantity measurement can be based on, and on the accurate calibration of the 
dosimetry system (Izewska & Rajan, 2005).  
To be effective, radiation dosimeters must display certain key features 
comprising sensitive response to dose, in which sensitivity is independent of dose 
rate and photon energy, stability over time with high accuracy, and measurement 
precision. In other words, an ideal dosimeter offers the following main features: a 
distinctive accuracy and reproducible response that is independent of energy; 
capability of measuring the dose with a high spatial resolution; a linear response over 
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a large dynamic range; non-disturbance of the dose to the medium; and the ability to 
measure the dose distribution in three dimensions. However, not all dosimeters can 
meet all of these requirements. Thus, the preference for a radiation dosimeter and its 
reader must be made systematically, taking into consideration the requirements of the 
measurement conditions (Rosenberg, 2008)   
1.2 Motivation for a 3D Dosimeter 
Different dosimeters have been used to measure the dose distributions. 3D 
dosimeters present more advantages over 1D dosimeters, such as ionization 
chambers (ICs), or 2D dosimeters, such as radiosensitive films, given that the 
absorbed radiation dose distribution may be recorded in three dimensions based on 
the type of gel dosimeter utilized. Verifying dose distribution is greatly required in 
conditions involving intricate dose distributions, such as stereotactic radio-surgery 
(STR) or intensity-modulated radiotherapy (IMRT). In addition, gel dosimeters may 
be adapted to become equivalent to soft tissue, and their physical properties may be 
altered to meet the requirements of certain applications (Ataei, 2012). 
The 3D radiation dosimeters are derived from radiation-sensitive materials 
that undergo transformations in their physical and chemical properties upon 
irradiation, as a basis for absorbed radiation dose. These transformations, including 
changes in color, transparency, and density, are measurable (Hurley et al., 2006; 
Vértes et al., 2010). The response of a model 3D dosimeter is supposed to be firm, 
explicit, measurable, and reproducible (De Deene, 2004; Baldock et al., 2010). The 
response should be insensitive to variations in environmental conditions during 
irradiation and scanning, such as light, humidity, temperature, and pressure.  
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The response of the 3D dosimeter requires basis on the total radiation dose 
distribution, but should not be subjective to the radiation dose rate or to the energy 
transmitted by the radiation beam. However, as radiation delivery techniques 
increase in complexity, the need for an accurate and practical 3D dosimetry system 
has increased as an essential requirement for validating dose distributions. In 
addition, the 3D dosimetry system has undergone a series of developments and 
improvements (Oldham, 2006). Over the past two decades, several 3D radiation 
dosimeters have been proposed, among which the Frick gel dosimeter and polymer 
gel dosimeters are dominant (Gore & Kang, 1984; Maryanski et al., 1994a; 
Vandecasteele et al., 2011). 
In 1984,  Gore et al. introduced the Fricke solution, which was initially 
highlighted by Fricke and Morse (1927), via integrating the solution into a gel matrix 
as a radiation-sensitive gel that could potentially be used to measure 3D dose 
distribution (Davies & Baldock, 2008). The Fricke gel dosimeter involves the use of 
magnetic resonance imaging (MRI) to detect and quantify radiation-induced changes 
and dose-dependent transformation of ferrous (Fe
2+
) into ferric (Fe
3+
) ions in Fricke 
or ferrous sulfate solutions. Fricke gels have garnered considerable interest as 3D 
dosimeters given their simple preparation and reproducible results (Schreiner, 2004). 
However, similar to other conventional gels used in dosimetry, Fricke gels are 
sensitive to the preparation conditions and procedure, including irradiation and read-
outs such as impurities and temperature. Conversely, polymer gel dosimeters 
comprise water and gelatin, as well as monomers and cross-linkers that polymerize in 
response to free radicals produced by water radiolysis (Baldock et al., 2010). The 
amount of cross-linked polymer that forms and precipitates at each site in the gel is 
dependent on the local radiation dose and the discrete concentration of monomer and 
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cross-linker. The tightly cross-linked polymer particles developed in the gel modifies 
the physical properties of the dosimeter. These changes can be detected using MRI, 
optical computerized tomography (CT), and x-ray CT scans (Maryanski et al., 1993; 
Jirasek et al., 2010; Olding et al., 2011). 
Gel dosimeters are radiosensitive materials that undergo transformations in 
their chemical configuration upon irradiation, which acts as a basis for absorbed 
radiation dose. These dosimeters may be recorded the dose distribution in 3D based 
on the type of gel dosimeter utilized (Jirasek et al., 2009; Rozlan et al., 2011). 
1.3 Genipin Gel Dosimeter   
Genipin (GP) gel dosimeters are hydrogels infused with a radiation-sensitive 
material possessing the ability to retain dosimetric information in three dimensions. 
Over the years, in addition to its use in herbal medicine, genipin  has shown more 
potential distinctive features, such as its biocompatibility and low cytotoxicity 
(Butler et al., 2003; Fernandes et al., 2013). Genipin radiochromic gel has also 
exhibited considerable potential as a 3D dosimeter in advanced radiotherapy 
techniques. Several studies have investigated the characteristics and applications of 
genipin . Using NMR spectroscopy, Djerassi et al. (1961) analyzed the chemical 
structure of genipin , which possesses the molecular formula of C11H14O5. genipin  
has also been cross-linked with amino acid to create stable cross-linked products 
with dark blue pigments (Lee et al., 2003). Recently, Jordan (2008) introduced the 
application of genipin  gel as 3D dosimeter. Subsequently, various research studies 
have been conducted to evaluate the application of genipin in radiotherapy 
applications. For example, Jordan (2009) reported that genipin –gelatin combination 
presents an adequate response for radioactive dosage up to 50 Gy.  
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Furthermore, Davies et al. (2013) demonstrated that a genipin –gelatin gel 
does not diffuse post-irradiation, which is a limiting feature of any gel dosimeter 
infused with radiation-sensitive species. Instead, the genipin  hydrogel is bleached as 
a monotonic function of dose upon irradiation, and the color change can be optically 
quantified as an indication of absorbed dose (Cho et al., 2009), thereby facilitating 
the mapping of absorbed dose distribution in three dimensions with sufficient 
stability and sensitivity for doses up to100 Gy (Davies et al., 2010). Furthermore, 
Davies et al. (2011) asserted that the addition of sulfuric acid increases the sensitivity 
of genipin gel dosimeter for quality assurance of radiotherapy level dosimetry. This 
improvement thus ensures the material’s potential value as a dosimeter for 
applications such as the phytosanitary irradiation treatment of food. Gorjiara et al. 
(2011) studied the water equivalency of genipin  by characterizing its radiological 
properties. Their results indicate that genipin gel exhibits greater water equivalency 
in comparison with polymer gels and PRESAGE
®
 formulation. 
1.4 Gold Nanoparticles (AuNPs) in Radiotherapy 
AuNPs is notable as one of most efficient and well-studied agents for 
enhancing radiation dose (Jain et al., 2012). Gold is as an inert material but can be 
easily mobilized with biocompatible coatings. Although, AuNPs are generally 
harmless and non-toxic to human, additional studies are needed, given that high 
doses may definitely be connected to toxicity (Xi et al., 2012). A number of studies 
have reported that the change of the biocompatible surface and polymer coating 
lowers the toxicity of AuNPs (Zhang et al., 2008; Kong et al., 2008; Rahman et al., 
2009; Liu et al., 2010).  
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AuNPs were originally classified as potential radiation enhancing agents for 
in vivo computed tomography (CT) imaging by Hainfeld et al. (2014). They 
concluded that the relatively higher Z number of gold (Au = 79) in contrast to the 
usually used iodine (I = 53), and its considerably higher absorption coefficient, lead 
to a 3 times greater contrast per unit weight for gold compared to iodine. AuNPs also 
demonstrate great potential as contrast agents for imaging functions performed prior 
to delivery of treatment such as in Image-guided radiation therapy (IGRT) (Jackson 
et al., 2010; Kim & Jon, 2012). Consequently, treatment supported by AuNPs has 
added benefits such as the prospect of real-time imaging of targets during and post 
irradiation; hence, it has the potential to be employed in image-guided radiotherapy. 
Based on potential therapeutic applications of AuNPs in radiotherapy, their 
dose enhancing capabilities have been investigated in several in vitro investigations 
(Sperling et al., 2008; Rahman et al., 2009; Chithrani et al., 2010; Jain et al., 2011). 
Monte Carlo simulations have also been used to hypothetically simulate and compute 
the interactions between AuNPs with diverse types of surface treatment techniques 
and beam energies (Cho, 2005; McMahon et al., 2008; S. X. Zhang et al., 2009). 
Most of these computational simulations showed that low energy x-rays and gamma-
rays are more effective in enhancing radiation doses than the high energy ones.  
  All above mentioned studies have suggested the increase in photoelectric 
absorption by high Z materials at kilovoltage photon energies as the rationale 
supporting AuNPs dose enhancement. Such dose enhancement would not occur at 
clinically related megavoltage energies, since Z-independent Compton interactions 
are dominant (Podgorsak, 2010). Despite this, a number of studies have related the 
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increase in cell death by AuNPs with clinically relevant megavoltage energies (Jain 
et al., 2011; Tsiamas et al., 2013).   
1.5 Problem Statement 
The delivery of radiation therapy to tumors is a highly complex and technical 
medical treatment (Van Dyk, 1999; Khan, 2010). Hence, radiation measurements, 
investigations of radiation effects, and radiation dosimetry necessitate a range of 
specifications of the radiation field at the point of interest to determine the energy 
deposited in a given medium quantitatively, either directly or indirectly, by IR. The 
use of genipin  gel as 3D dosimeter has been effective because of its biocompatibility 
and low toxicity (Butler et al., 2003; Fernandes et al., 2013). In addition, genipin  gel 
presents high water equivalence and sensitivity for radioactive doses up to 100 Gy 
(Davies et al., 2010). 
However, the material possesses a relatively low melting point of 25 °C 
(Davies et al., 2013) and requires a long time for imaging. In addition, gel 
transportation makes genipin  susceptible to flaccidity, so the 3D mapping recorded 
in the gel would be lost (Zhu et al., 2010; Pavoni & Baffa, 2012), which decreases 
sensitivity to IR. Therefore, this study hypothesizes that increasing the melting point 
or rigidity of genipin and adjusting its density with the addition of certain chemical 
components, such as glucose, AuNPs, and inorganic salts, to its original recipe will 
improve the dosimetric properties of this dosimeter and maintain its dose sensitivity 
at an acceptable level. 
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1.6 Significance of Study 
In an effort to reduce patient morbidity and increase clinical outcomes, a high 
demand is placed on the accuracy and precision of dosimetric parameters. Melting 
point in gel dosimetry is an important factor that affects the validity and capability 
for 3D dose measurements. This parameter, in particular, is crucial for when the 
gel melts, resulting in discrepancy of the 3D mapping recorded in the gel (Zhu et al., 
2010; Pavoni & Baffa, 2012). Given that the gel melting point of genipin is still 
below the required level, increasing the melting point will improve its rigidity, 
transparency, and optical dose response. The feasibility of employing three different 
chemical additives (inorganic salt, glucose, and gold nanoparticles (AuNPs)) to 
enhance the dosimetric properties of genipin gel was investigated using optical 
evaluation and CT scan techniques.  
Therefore, attempts will be conducted to enhance the dosimetric properties of 
genipin gel by means of experimental studies using AuNPs on gel irradiated with 0 
Gy to 15 Gy ranges of radiation doses at different concentrations of AuNPs for two 
energies of external radiation (6 and 10 MV). Glucose will be used to improve the 
melting point and increase gel rigidity, while AuNPs will be applied to enhance the 
radiation response of the gel. Two evaluation techniques, namely, optical evaluation 
and x-ray CT, will be used to verify the 3D radiation dose distributions subsequent to 
the use of these additives. Improving the melting point will ensure easier integration 
into the clinical environment.  
Furthermore, dose distributions predicted by treatment planning systems 
(TPS) and dose distribution measured through a phantom require confirmation by 
accurate dosimetric measurements to be used directly in clinical practice. To achieve 
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optimal agreement between computed dose distributions by the planning systems and 
actual delivered dose distributions by a linear accelerator, genipin gels and EBT3 
radiochromic films were compared, and IC dosimeter measurements were 
investigated to verify the capability of genipin gels for determining dose distributions 
before introduction into clinical practice.  
1.7 Objectives of the Study 
The overall aim of this study was to enhance certain physical and radiological 
properties of genipin gel dosimeter by utilizing several chemical additives. The 
specific objectives of this study are:  
1. To fabricate and optimize the concentrations of the different chemical 
components of genipin gel dosimeters.  
2. To assess the effect of chemical additives, namely, AuNPs, inorganic salts and 
glucose of genipin gel dosimeters.  
3. To characterize the genipin gel in therapeutic photon beam and verifying the 
dosimeter stability. 
4. To evaluate the tissue equivalency of genipin gels in terms of dosimetric 
parameters over a wide energy range of x-ray. 
1.8 Scope of Research 
This research introduces a new formulation to fabricate low-cytotoxicity gel 
dosimeter with the capability of mapping the absorbed dose distribution in three 
dimensions. Typical genipin gel was found to be composed of gelatin as a gelling 
agent, genipin as a cross-linker, ultrapure water and sulfuric acid. Genipin gel 
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batches were prepared by varying chemical composition and stored 24 hours at ~4°C 
for gelation. Irradiation of gel samples was performed using 6 and 10 MV photon 
beams delivered by a dual-energy linear accelerator (LINAC) with Siemens 
PRIMUS
TM
 LINAC electron beam facility, at Mount Miriam Cancer Center 
Hospital, Penang, Malaysia. From the onset of the research, the optimal elemental 
composition of the dosimeter was proposed according to gel rigidity, transparency, 
radiological properties, and optical dose response. The gels were irradiated to doses 
up to 20 Gy; the optical dose-response of genipin gel appears to be linear over a dose 
range up to 15 Gy. Genipin gel dosimeters were read out using x-ray CT and UV–
visible spectrophotometer evaluation techniques.   
Afterward, the feasibility of employing several chemical additives, namely, 
AuNPs, inorganic salts and glucose for enhancing the genipin gel dosimetric 
properties is examined. Moreover, a comparison between genipin gels and EBT3 
radiochromic films and ion chamber dosimeter measurements was investigated to 
verify the capability of genipin gels for determining dose distributions before 
introduction into clinical practice. However, formaldehyde has been also tasted as 
additive to improve the gel melting point; it didn’t show any improvement of genipin 
gel melting point.  
1.9 Thesis Outline 
This thesis includes five individual chapters. Chapter one provides a brief 
introduction to history and development of gel dosimetry; followed by the problem 
statement, research significance and research objectives. Chapter 2 presents the 
theoretical background followed by a comprehensive review of the study. It first 
clarifies the theoretical background of the main interactions of photons with matter, 
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x-ray production and attenuation. Furthermore, this chapter provides the strengths 
and limitations of the field of study through a comprehensive review of the literature 
and identifies the most important backgrounds related to this thesis.  
Chapter 3 presents in detail the research methodology involving the 
experimental procedures of genipin gel dosimetry in terms of materials ,devices and 
techniques used for fabrication, irradiation and reading out. It also outlines the 
method of evaluating the gel density, some physical and radiological properties, 
surface dose, and depth dose profile of the optimal gel formulations.  
 Chapter 4 entails the results and discussion of all the experiments performed 
in this study; the optimal gel composition and formulations for maximum visible 
absorption dose response, the effect of variation of the gel components weight 
fractions in melting point mass, density, the temporal stability and the reproducibility 
measurements of genipin gel dosimeter. In addition, the experimental results of the 
feasibility of employing glucose and AuNPs to enhance genipin gel dosimetric 
properties. Eventually, Chapter 5 presents the major findings of this thesis, and gives 
suggestions for future work with regard to this research. 
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CHAPTER 2 
THEORETICAL BACKGROUND AND LITERATURE REVIEW 
 
2.1 Main Interactions of Photons with Matter 
Ionizing radiations are classified as direct and indirect. Direct ionizing 
radiation includes charged particles, such as α and β particles, protons, and electrons 
that interact with matter mainly by Coulomb forces. Indirect ionizing radiation 
includes particles with no charge; when interacting with matter; uncharged particles 
can transfer energy by direct collision with orbital electrons or nuclear interactions, 
such as, neutron, gamma, and x-rays. 
X-ray photons may also be classified according to photon energy. For 
instance, photons with kinetic energy ranging from 20 keV to 100 keV are superficial 
or soft X-rays; those with kinetic energies ranging from 200 keV to 400 keV, 400 
keV to 800 keV, and >1,000 keV are orthovoltage, supervoltage and megavoltage x-
rays, respectively (Goldschmidt et al., 1991; Jones, 1994). Studies regarding the 
interaction of a photon beam with matter have attained a significant importance in 
science and technology. Precise knowledge of the mechanism by which radiations 
interact with matter is required to understand diffusion and penetration of radiations 
in a medium. With advancements in technology, gamma ray, and x-ray spectroscopic 
techniques, numerous applications in diverse fields, such as medicine, have been 
developed (Aichinger et al., 2011). 
As a photon beam passes through matter, each photon undergoes three 
possible fates: a photon can penetrate matter without interaction; a photon can be 
completely absorbed by depositing energy; or a photon can interact with matter and 
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can be scattered from its original direction and deposit part of its energy (Attix, 2008; 
Fosbinder & Orth, 2011). As x-rays travel through a patient’s tissue, intensity 
attenuates exponentially because of complete or partial loss of x-ray photon energy; 
either complete energy loss termed absorption or partial energy loss called scattering 
may occur (Nikjoo et al., 2012). However, several interaction events are usually 
involved as x-ray photons interact with tissues; these interactions include 
photoelectric effect, scattering, and pair production in which Compton scattering is 
dominant at a therapeutic energy range (Kurudirek & Topcuoglu, 2011). However, a 
brief description of each interactions mechanism is provided below. 
2.1.1 Photoelectric Effect 
Photoelectric effect is an electro-quantum phenomenon in which photon 
energy is absorbed by an orbiting electron of an atom. If photon energy is greater 
than binding energy of an electron, which differs in various types of matter, this 
electron is ejected from an atom; such an electron is called a photoelectron that 
creates a vacancy in a shell; thus, the atom becomes excited after a photoelectron is 
emitted. The kinetic energy of a photoelectron is calculated using Eq.2.1: 
                  (2.1) 
where Ek, , E0 and Eb are kinetic energy of the photoelectron, the energy of initial 
input photon, and the electron binding energy, respectively. The photoelectric 
phenomenon is illustrated in Figure 2.1. 
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Figure ‎0: A diagram of the photoelectric phenomenon (Fosbinder & Orth, 2011). 
The probability of photoelectric absorption depends on Z of an absorber and 
photon energy; it is inversely proportional to the cube of photon energy. Therefore, 
photoelectric effect is significant in photons, such as diagnostic x-rays, with low 
energy of <100 keV. The proportionality of this interaction is generally expressed as:  
                    (2.2) 
where   is the probability of the photoelectric effect, Z is the atomic number of the 
bombarded matter, n is 3 or 4 depending on the energy of the photon, and    is the 
energy of the primary photon (Saha, 2012) 
2.1.2 Rayleigh (Coherent) Scattering 
Coherent scattering is the interaction of photons with matter when low-
energy photons pass through an element with a high atomic number and change 
direction without any energy loss and without changing wavelengths before and after 
interaction occurs. Figure 2.2 shows the schematic of coherent scattering  
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Figure 2.2: The schematic diagram of the coherent scattering (Fosbinder & Orth, 2011). 
 
The coherent scattering is an elastic scattering that also is known as 
Thompson, classical, or Rayleigh scattering (Hobbie & Roth, 2007; Attix, 2008). 
This phenomenon occurs primarily at energies <10 keV but is not important in 
therapeutic and diagnostic radiology. 
2.1.3 Compton Scatter (Incoherent Scatter) 
In Compton scattering, an x-ray photon loses its energy and changes its 
direction as this X-ray photon interacts with matter. Therefore, the x-ray wavelength 
after Compton scattering is greater than that before scattering. Compton scattering 
equation is expressed as: 
 
                   
 
   
             (2.3) 
where λ and λ′ are the wavelengths of x-ray photons before and after Compton 
scattering; h, me, c, and   are Planck’s constant, electron rest mass, speed of light, 
and angle of scattered x-ray photons, respectively. The amount of Compton 
scattering increases as x-ray energy increases. Compton photons can be scattered in 
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any path not exceeding 180°. Deflection angle is generally controlled by the energy 
of the initial photon. At a deflection angle of 0°, no energy is transmitted because 
photon does not vary from the initial direction. As deflection angle increases to 180°, 
additional energy is provided for the recoil electron, and the energy retained in the 
scattered photon is reduced. Nonetheless, Compton scattering is usually the main 
mechanism of a therapeutic array of energies ranging from 100 keV to 1 MeV 
(Oldham, 2001; Long et al., 2012). A Compton-scattered x-ray photon is 
characterized by lower energy and longer wavelength than the incident photon 
(Figure 2.3). 
 
Figure 2.3:Illustrates Compton scattering of an incident x-ray by an outer-shell electron 
(Fosbinder & Orth, 2011) 
 
2.1.4 Pair Production 
For energetic photons of >1 MeV, pair production is the dominant interaction 
mechanism. Electron rest mass energy is 0.51 MeV; thus, the photon with energy 
>1.02 MeV can create a pair of electron and positron (anti-mass particle of the 
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electron) by interacting with the nucleus of an atom (Tavernier, 2010). The photon 
disappears in the nuclear field of absorber atoms; thus, one electron–positron pair is 
generated. Figure 2.4 shows a simple schematic of pair production. 
 
Figure 2.4: Pair production occurs with x-ray photons having an energy of 1.02 MeV or 
greater. Upon interaction with the nuclear force field, the photon disappears and two 
oppositely charged electrons take its place (Fosbinder & Orth, 2011) 
 
2.2 Production of X-Rays 
In 1895, Wilhelm Röntgen called his newly discovered radiation as x-ray 
because of its cryptic nature. X-rays are high-energy electromagnetic waves 
(Hessenbruch, 2002; Slater, 2012). In retrospect, the image of Röntgen’s wife’s left 
hand was the first published utilization of x-rays. Since this discovery, x-rays have 
been considerably applied in diagnostic imaging and therapy (Short & Bonner, 1989; 
Cherry & Duxbury, 2009). 
However, x-rays are produced by interactions in atomic shells. In a 
conventional method, x-ray photons are generated by emission of electrons from a 
filament (cathode); the emitted electrons are then accelerated with a voltage toward a 
 20 
metallic target (anode); these electrons subsequently strike the target, thereby 
converting a small fraction of their kinetic energy into x-ray photons. With these 
interactions between a target element and electrons, x-ray is produced with different 
spectra depending on specific elements. In this process, an x-ray device emits two 
different types of x-ray photons via physical mechanisms: bremsstrahlung and 
characteristic x-ray (Van Grieken & Markowicz, 2001; Zschornack, 2006; Allisy-
Roberts & Williams, 2007).  
2.2.1 X-Ray Tubes 
A conventional x-ray tube (Figure ‎05) consists of a partially evacuated glass 
envelope that contains two electrodes: a negative electrode known as cathode and a 
positive electrode called anode. The two electrodes are maintained at a sufficient 
potential difference. The cathode located on one side of the x-ray tube contains a 
filament; electrons are produced as current is applied on this filament; these electrons 
then interact with the anode, which contains the focal spot involved in x-ray 
production, on the opposite side of the x-ray tube (Fosbinder & Orth, 2011; Khan & 
Gibbons, 2014).  
 
Figure 2.5: Components of a typical x-ray tube (Fosbinder & Orth, 2011) 
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2.2.2 Characteristic X-Ray Spectrum 
Electron transitions between quantized atomic energy levels provide photons 
with definite wavelengths in visible, UV, and x-ray regions of the electromagnetic 
spectrum. The energy of these photons is distinct from each atom relative to the 
binding energy of the target electrons, given that electron binding energies depend on 
Z (Bushberg & Boone, 2011). Vacancies are created when an incident electron 
exhibits sufficient energy to eliminate an orbital electron from an inner electron 
shell; thus, atoms become unstable. Afterward, a high-energy outer-shell electron 
instantly fills low-energy vacancy that creates a characteristic x-ray photon. This 
shift in electrons between shells is referred to as characteristic cascade, which can 
create several x-ray photons for each electron removed from an atom (Beyzadeoglu 
et al., 2010; Fosbinder & Orth, 2011). 
In addition, characteristic x-rays are identified according to the orbital 
affected by vacancy. For example, radiations stemming from the occurrence of 
vacancies in K and L shells are referred to as K- and L-characteristic x-rays, 
respectively. If a vacancy in one shell is filled by an adjacent shell, this vacancy is 
recognized by a subscript alpha (e.g., L → K transition K, M → L transition L). If 
an electron vacancy is filled by a non-adjacent shell, the subscript beta is used e.g., M 
→ K transition K) (Hendee & Ritenour, 2003; Bushberg & Boone, 2011; Khan & 
Gibbons, 2014). The energy of the characteristic x-ray is a measure of the disparity 
between electron binding energies (Eb) of the respective shells expressed as: 
                                                                       (2.4) 
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2.2.3 Bremsstrahlung Spectrum 
In an x-ray tube, a cathode system can accelerate electrons across a vacuum 
glass tube toward the anode. These electrons then penetrate the anode material by 
passing close to its atomic nuclei. A coulomb field of these nuclei causes incident 
electrons to deflect from their initial path. Indeed, in an individual deflection by a 
target nucleus, incident electrons can radiate different amounts of energy from zero 
to its total kinetic energy (T) depending on how close it approaches the target 
nucleus. The energy lost by an incident electron during this encounter appears in the 
form of an x-ray photon (Dowsett et al., 2006). 
Bremsstrahlung (brems) is produced when accelerated electrons are slowed 
down in different rates by the coulomb field of the anode nuclei. The incident 
electron must have enough energy to be closed to target nucleus. As a result, the 
force fields make the electron decelerate or brake and then cause a deflection in the 
electron directions. According to energy conservation law, an electron loses different 
amounts of kinetic energy emitted as brems x-ray photon. The amount of lost kinetic 
energy depends on how close to the nucleus an incident electron is. For instance, 
more energy is lost when an incident electron is close to the nucleus, producing high-
energy brems photon (Fosbinder & Orth, 2011). Consequently, this kind of radiation 
spectrum is continuous; by contrast, characteristic x-ray spectrum contains 
sharp spectral lines. Most of the produced x-ray beams exhibit an average energy of 
approximately one-third to one-half of the maximum energy (Seibert & Boone, 
2005). Figure 2.6 illustrates the mechanisms by which bremsstrahlung and 
characteristic x-rays are produced.  
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Figure 2.6: Illustrates how the two-production process of x-ray; bremsstrahlung (a) and 
characteristic x-ray (b)  
 
2.3 X-Ray Attenuation 
As an x-ray beam is directed to an absorber, some of the photon beams 
interact and become completely absorbed or scattered at a large angle from its 
original path; thus, part of their energy is deposited. Other photon beams completely 
pass through an absorber without interaction. As a result of either photoelectric or 
Compton interaction between photons and an absorber, the intensity of an incident 
photon beam decreases as the beam travels through a certain thickness of the 
absorber. This loss of photon intensity is called attenuation. 
2.3.1 Linear Attenuation Coefficient 
For a beam of mono-energetic photons, the intensity of photon beams 
decreases because of interactions as these photons pass through an attenuator, 
leading to exponential attenuation; in exponential attenuation, the decrease in beam 
intensity is determined mainly by thickness, density, and atomic number of the 
 
(a) (b) 
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attenuator (Seegenschmiedt et al., 2009; Powsner et al., 2013). Figure 2.7 illustrates 
the concept of linear attenuation coefficient (Radiation & (ARPANSA)) according 
the penetration and intensity reduction of the incident photons beam through an 
attenuator. 
 
Figure 2.7:Schematic diagram showing attenuation and transmission of x ray through 
absorber (Gunderson & Tepper, 2012) 
 
If the beam intensity at the exit point of the attenuator is I and the initial 
intensity of the incident beam is I0, then µ is expressed as an exponential function of 
the thickness t of the attenuator in cm; the intensity of the beam decreases 
exponentially with the thickness of the absorber, and µ is typically measured in cm
−1 
(Fosbinder & Orth, 2011). Thus, µ may be quantified as:  
 
     
    
  
        (2.5) 
µ increases linearly with attenuator density ρ; therefore, a dense material exhibits 
great attenuation. For instance:  
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